SYNAPS Dx (SDx) is pleased to present “Physicians’ Assessment of the Clinical Utility of a Novel Test to Diagnose Alzheimer’s Disease (AD),” at the Professional Society for Health Economics and Outcomes Research (ISPOR) Annual Conference, May 15-18, 2022, in National Harbor, Maryland. Our implicit preference study indicates that 90% of physicians would routinely use the results of DISCERN™, a diagnostic test …
Input your search keywords and press Enter.
Recent Comments